EMSY Haplotype Structure — The Hidden Context Behind the 11q13.5 Allergy Signal
The well-known rs7927894 T allele at chromosome 11q13.5 is one of the most replicated
atopic dermatitis susceptibility signals in the human genome — but the full story of this
locus requires a second variant. Ponińska et al. (2017)11 Ponińska et al. (2017)
Ponińska et al., PLoS One 2017 —
participants from the ECAP (Epidemiology of Allergic Diseases in Poland) cohort
including subjects with atopic dermatitis, atopic asthma, and persistent allergic rhinitis
plus matched controls showed that the risk
conferred by rs7927894 T is not carried by the T allele alone: it is haplotype-dependent,
and specifically requires the G allele at rs7125552 to manifest. Without G at this position,
the rs7927894 T allele's association with atopic dermatitis and allergic rhinitis disappears.
This kind of haplotype dependency is clinically meaningful: it means that genotyping rs7927894 alone gives an incomplete picture of this locus's risk contribution. rs7125552 is the contextual marker that defines whether the risk haplotype is complete.
The Mechanism
rs7125552 sits at position 76,500,050 on chromosome 11 (GRCh38, NC_000011.10:g.76500050G>A),
approximately 90 kilobases upstream of rs7927894 (position 76,590,272) within the EMSY gene
body. Both variants lie within the same topologically associating domain (TAD) that encompasses
EMSY and LRRC3222 EMSY and LRRC32
EMSY (C11orf30) is a chromatin regulatory protein that epigenetically
suppresses skin barrier genes including filaggrin and ceramide synthesis enzymes; LRRC32
encodes GARP, a TGF-β receptor complex component on regulatory T cells — both genes contribute
to allergic susceptibility through distinct mechanisms at the same genomic address.
The Evidence
The Ponińska et al. haplotype analysis across ECAP cohort participants is the key evidence for this variant's role. In single-SNP analysis, rs7125552 showed no significant independent association with atopic dermatitis (OR=1.08, p=0.49). Its importance emerges at the haplotype level: the TG haplotype (T at rs7927894, G at rs7125552) carried an OR of 1.92 (p=0.00021) for atopic dermatitis and OR=1.32 (p=0.023) for persistent allergic rhinitis. In contrast, the TA haplotype (T at rs7927894, A at rs7125552) had OR=1.12 (p=0.36) — statistically indistinguishable from no effect. This demonstrates that rs7125552 G is not merely a passenger — it is structurally required for the allergy risk haplotype to be functional.
The 11q13.5 locus was confirmed as a key atopic march locus in a 2015 meta-analysis33 2015 meta-analysis
Marenholz et al., Nat Commun 2015 and in the large
Paternoster et al. meta-GWAS44 Paternoster et al. meta-GWAS
Nat Genet 2011 — 5,606 cases and 20,565 controls in
discovery; 5,419 and 19,833 in replication.
These studies replicate the 11q13.5 association; the Ponińska work adds the mechanistic
detail that the haplotype — not a single SNP — is the functional unit.
Practical Actions
The actionable implications of rs7125552 mirror those of its haplotype partner rs7927894, because the two variants define the same functional unit. Carriers of G at rs7125552 who also carry T at rs7927894 are on the complete high-risk haplotype (TG), with an approximately twofold increased risk for atopic dermatitis.
Carriers of AA at rs7125552 represent the minority (approximately 9%) who carry two copies of the haplotype-breaking A allele — these individuals appear protected from the rs7927894 T risk effect even if they carry T alleles at that position.
Interactions
The central interaction is the cis-haplotype with rs7927894: these two variants at 11q13.5 are best interpreted as a functional unit rather than as independent signals. The high-risk haplotype is T (rs7927894) + G (rs7125552); the protective configuration requires A at rs7125552.
Beyond the cis interaction, the 11q13.5 locus interacts with filaggrin loss-of-function variants (rs61816766 and rs12123821) through converging effects on skin barrier integrity. The IL13 variant rs20541 operates from the immune activation side of the same atopic phenotype and compounds the total risk carried by 11q13.5 haplotype carriers.